XML 47 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   211,091,425      
Beginning balance at Dec. 31, 2022 $ 126,654 $ 2,110 $ 504,767 $ (1,893) $ (378,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Private placement of common stock/ Rights offering of common stock, net of offering costs (in shares)   476,190,471      
Private placement of common stock/ Rights offering of common stock, net of offering costs 499,381 $ 4,762 494,619    
Issuance of common stock under stock purchase plans and exercise of stock options and warrants (in shares)   403,469      
Issuance of common stock under stock purchase plans and exercise of stock options and warrants 651 $ 4 647    
Issuance of common stock in lieu of cash for Akeso upfront payment (in shares)   10,000,000      
Issuance of common stock in lieu of cash for Akeso upfront payment 45,900 $ 100 45,800    
Stock-based compensation 4,650   4,650    
Net changes related to short-term investments 3     3  
Reclassification of cumulative translation gain (Note 8) (419)     (419)  
Foreign currency translation adjustment (128)     (128)  
Net loss (557,093)       (557,093)
Ending balance (in shares) at Jun. 30, 2023   697,685,365      
Ending balance at Jun. 30, 2023 119,599 $ 6,976 1,050,483 (2,437) (935,423)
Beginning balance (in shares) at Mar. 31, 2023   697,685,365      
Beginning balance at Mar. 31, 2023 133,482 $ 6,976 1,048,608 (1,396) (920,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,875   1,875    
Net changes related to short-term investments (965)     (965)  
Reclassification of cumulative translation gain (Note 8) 0        
Foreign currency translation adjustment (76)     (76)  
Net loss (14,717)       (14,717)
Ending balance (in shares) at Jun. 30, 2023   697,685,365      
Ending balance at Jun. 30, 2023 $ 119,599 $ 6,976 1,050,483 (2,437) (935,423)
Beginning balance (in shares) at Dec. 31, 2023 701,660,053 701,660,053      
Beginning balance at Dec. 31, 2023 $ 77,692 $ 7,017 1,066,381 (2,448) (993,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Private placement of common stock/ Rights offering of common stock, net of offering costs (in shares)   22,222,222      
Private placement of common stock/ Rights offering of common stock, net of offering costs 200,000 $ 222 199,778    
Issuance of common stock under stock purchase plans and exercise of stock options and warrants (in shares)   437,926      
Issuance of common stock under stock purchase plans and exercise of stock options and warrants 697 $ 4 693    
Stock-based compensation 20,595   20,595    
Net changes related to short-term investments (34)        
Reclassification of cumulative translation gain (Note 8) 0        
Foreign currency translation adjustment 82        
Net other comprehensive loss (51)     (51)  
Net loss $ (103,858)       (103,858)
Ending balance (in shares) at Jun. 30, 2024 724,320,201 724,320,201      
Ending balance at Jun. 30, 2024 $ 195,075 $ 7,243 1,287,447 (2,499) (1,097,116)
Beginning balance (in shares) at Mar. 31, 2024   701,974,596      
Beginning balance at Mar. 31, 2024 44,210 $ 7,020 1,076,370 (2,449) (1,036,731)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Private placement of common stock/ Rights offering of common stock, net of offering costs (in shares)   22,222,222      
Private placement of common stock/ Rights offering of common stock, net of offering costs 200,000 $ 222 199,778    
Issuance of common stock under stock purchase plans and exercise of stock options and warrants (in shares)   123,383      
Issuance of common stock under stock purchase plans and exercise of stock options and warrants 212 $ 1 211    
Stock-based compensation 11,088   11,088    
Net changes related to short-term investments (45)        
Reclassification of cumulative translation gain (Note 8) 0        
Foreign currency translation adjustment 92        
Net other comprehensive loss (50)     (50)  
Net loss $ (60,385)       (60,385)
Ending balance (in shares) at Jun. 30, 2024 724,320,201 724,320,201      
Ending balance at Jun. 30, 2024 $ 195,075 $ 7,243 $ 1,287,447 $ (2,499) $ (1,097,116)